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ABSTRACT
Alternative splicing enables higher eukaryotes to
increase their repertoire of proteins derived from a
restricted number of genes. However, the possibility
that functional diversity may also be augmented by
splicing between adjacent genes has been largely
neglected. Here, we show that the human mela-
nocortin 1 receptor (MC1R) gene, a critical compo-
nent of the facultative skin pigmentation system,
has a highly complex and inefficient poly(A) site
which is instrumental in allowing intergenic
splicing between this locus and its immediate down-
stream neighbour tubulin-b-III (TUBB3). These tran-
scripts, which produce two distinct protein isoforms
localizing to the plasma membrane and the endo-
plasmic reticulum, seem to be restricted to
humans as no detectable chimeric mRNA could be
found in MC1R expressing mouse melanocytes.
Significantly, treatment with the MC1R agonist
a-MSH or activation of the stress response kinase
p38-MAPK, both key molecules associated with
ultraviolet radiation dermal insult and subsequent
skin tanning, result in a shift in expression from
MC1R in favour of chimeric MC1R-TUBB3 isoforms
in cultured melanocytes. We propose that these
chimeric proteins serve to equip melanocytes with
novel cellular phenotypes required as part of the
pigmentation response.
INTRODUCTION
The melanocortin 1 receptor (MC1R) is one of ﬁve
G-protein coupled receptors belonging to the melanocortin
subfamily, associated with the regulation of a variety of
fundamental biological processes ranging from pigmenta-
tion and energy homeostasis to sexual health (1). MC1R is
expressed on the cell surface of epidermal melanocytes
located in the stratum basale of human skin and is an
integral part of the constitutive and facultative pigmenta-
tion system (2). The role of human MC1R in facultative or
adaptive pigmentation following ultraviolet radiation
(UVR) exposure has been the subject of intensive investi-
gation during the last few decades with more than 60
variant MC1R receptors identiﬁed, many associated with
phenotypic traits such as red hair, fair skin (3–5) and skin
cancer susceptibility (6–8).
MC1R acts between UVR stressed keratinocytes
located in the stratum spinosum and the production and
subsequent transfer of protective melanin from melano-
cytes. Although the melanocyte stimulating hormone
a-MSH has long been implicated in skin pigmentation
(1), a direct link between a-MSH, MC1R and UVR
induced tanning has only recently been demonstrated
(9). The binding of a-MSH to MC1R receptors triggers
multiple signal transduction cascades, primarily depend-
ent on elevated intracellular cAMP (10), resulting in the
activation of a large number of genes (11) which together
regulate several aspects of melanocyte biology such as pro-
liferation, melanogenesis (12) and cell-cycle control (11).
The activation of melanocytes by a-MSH and other para-
crine factors also elicit functionally signiﬁcant morpho-
logical changes. Critically, a-MSH binding to MC1R
stimulates melanocyte dendricity (13–15) and so increases
the number of individual keratinocytes a given melanocyte
can contact. This is crucial in facilitating maximal transfer
of melanin containing melanosomes along dendrites to
target keratinocytes where the melanin is subsequently
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associated caps.
The gene encoding MC1R is located on the 30-telomeric
end of chromosome 16 in a locus that has a high density of
genes. Consequently, only 2.5kb of intergenic DNA
separate MC1R from the downstream, tandem positioned
Tubulin beta III gene (TUBB3). As with many G-protein
coupled receptor genes, MC1R is expressed primarily as
an intronless gene. We earlier reported that MC1R has an
unusual cleavage and polyadenylation signal (PAS)
constituting an AAUAAA hexamer, a degenerate down-
stream sequence element (DSE) adjacent to the cleavage
site and ﬁnally two essential G-rich sequence elements
(GRS) located further downstream (16). This arrangement
is in contrast with normal bi-partite PAS comprising the
hexameric sequence A(A/U)UAAA and a GU or U rich
DSE in close proximity to the cleavage site (17).
Cleavage and polyadenylation is a highly regulated
co-transcriptional process that not only equips the
mRNA with a poly(A) tail essential for nuclear cytoplas-
mic export, stability and translation, but also triggers
transcription termination downstream of genes (18).
Importantly, alternative cleavage and polyadenylation,
which occurs in half of all protein-encoding genes (19),
is a signiﬁcant cellular process that controls the expression
of alternative mRNA isoforms in response to developmen-
tal and growth cues (20,21).
Here we present evidence that MC1R pre-mRNA is
subject to complex alternative processing that depends on
its unusual PAS. This allows readthrough transcription
into the downstream-positioned TUBB3 locus which
via alternative splicing results in the expression of at least
two novel chimeric mRNAs that contain both the MC1R
seven transmembrane receptor domain and a TUBB3
C-terminal extension. Strikingly, these chimeric transcripts
are human speciﬁc being absent in mouse melanocytes.
We demonstrate that these chimeric transcripts translate
into proteins which localize to the plasma membrane
and to the endoplasmic reticulum. Importantly, the expres-
sion levels of both MC1R and MC1R-TUBB3 chimeric
mRNA can be modulatedby stimulating discrete signalling
pathways associated with the dermal pigmentation
response to solar radiation.
MATERIALS AND METHODS
Cell culture and transfection
Cell lines HEK293 and HBL (human melanoma) were
cultured in DMEM/10%FCS/pen-strep/glutamine, whilst
cell lines B16 (mouse melanoma) and M14 (human
melanoma) were cultured in RPMI/5%FCS/pen-strep/
glutamine and RPMI/10%FCS/pen-strep/glutamine
respectively. Melan-a and Melan-c cells were cultured in
RPMI/10%FCS/pen-strep/glutamine supplemented with
200nM TPA, Melan-c cells were further supplemented
with 100mM b-mercaptoethanol. HERMES-1 cells
(which are transformed normal human melanocytes) (22)
were cultured in RPMI/10%FCS/pen-strep/glutamine
supplemented with 200nM TPA, 200pM Cholera toxin,
10nM endothelin-1 and 10ng/ml human stem cell factor.
All transfection were carried out as described previously
(16).
Plasmid construction
All human MC1R/TUBB3 locus constructs were cloned
from HeLa genomic DNA, using pfu DNA polymerase
ampliﬁcation, and inserted into either pUC18/CMV or
commercial pcDNA3.1-His expression vectors as previ-
ously described (16). The sequences of primers are avail-
able upon request. All constructs were veriﬁed by
complete sequencing.
pCMTR includes a CMV promoter AﬂIII-EcoRI fused
directly to the 50-UTR of MC1R followed by the entire
genomic locus for 16kb to the 43rd codon of TUBB3 exon
2 fused in frame Xba I to the entire RFP cDNA, followed
by a synthetic PAS SPA [synthetic poly(A) site] (23). In
pCMTR the CMV promoter is removed by an AﬂIII-
EcoRI digest. Constructs pCMTRi and pCMTRi
are derived from pCMTR and pCMTR where TUBB3
intron is removed fusing exons 1 and 2 in frame by PCR.
Construct pCiG is derived from pCMTR where the
30-end of the TUBB3 ﬁrst intron is fused 50 to an AﬂII
site 1-kb downstream of the MC1R PAS and 30 to exon2/
RFP. pCS6ki1 was created by an XhoI TUBB3 intronic
digest. pCG1G2 is based on the H36 construct [Dalziel
et al. (16)]. In pCSPA6ki1 the endogenous MC1R PAS
replaced by the artiﬁcial SPA, inserted via BlpI- AﬂII.
Constructs pE_MC1R, pE_Iso1 and pE_Iso2 were made
by Pfu ampliﬁcation from the appropriate cDNA and
inserted EcoRI/XbaI(AvrII) into the commercial construct
pcDNA3.1-v5His A (Invitrogen).
RNA extraction, RNase protection assay, 30-RACE
RNA extraction, RNase protection (RP) and 30RACE
were performed as previously described in Dalziel et al.
(16).
cAMP assay
All experiments were performed in duplicate and repeated
at least three times. HEK293 cells were seeded into 12-well
plates (Nunc) and grown overnight, then transfected
(overnight) with 0.25mg of a relevant
pcDNA3.1His-MC1R construct. Next day, cells were
serum starved for 1h in pre-warmed DMEM alone,
before being stimulated with NDP-MSH (10nM for 1h).
Total cellular cAMP was then measured with a commer-
cial kit (GE Healthcare) as per instructions.
Western blot, confocal microscopy
HEK293 cells transfected with pcDNA3.1-His MC1R
variants were washed (PBS) and solubilized in 200mlo f
solubilization buffer (50mM Tris–HCl, pH 8.0, 1% Igepal
CA-640, 1mM EDTA, 0.1mM PMSF and 10mM
iodoacetamide). The samples were subsequently vortexed
for 1h at 4 C, and centrifuged at 20800g for 30min.
Supernatants were used for subsequent western blotting.
Samples were incubated at room temperature for 30min
in sample buffer and subsequently loaded onto a 10%
Tris–Glycine polyacrylamide gel and semi-dry transferred
Nucleic Acids Research,2011, Vol.39, No. 6 2379to nitrocellulose in Towbin buffer. Detection of MC1R
variants was performed using the N19 antibody
(SantaCruz) and ECL.
HEK293 cells, grown on coverslips and transfected with
pcDNA3.1-His-MC1R variants, were washed in PBS,
ﬁxed with 4% paraformaldehyde, blocked with 2%
BSA. If needed, cells were permeabilized with 0.5%
Igepal-640. Cells were immunolabelled with the N19
anti-MC1R antibody (1:100) and the anti-goat Alexa488
secondary antibody (1:200). Photographs were taken in a
Zeiss LSM 510 Meta system.
RESULTS
MC1R 30-end processing requires a complex positional
arrangement of four cis-elements
Earlier we used an MC1R minigene to study cleavage and
polyadenylation in the context of an intronless gene (16).
This analysis revealed that the MC1R PAS requires four
sequence elements consisting of an AAUAAA hexamer, a
DSE and two GRS one located adjacent to the DSE
(GB1) and one positioned  400nt downstream of the
cleavage site (GB2). To further unravel the complexity
of the MC1R PAS, we decided to analyse the positional
requirements of nucleotides in the DSE and the GRS. We
previously showed that a di-uridine at position  24/ 25
downstream of the cleavage site is a critical component of
the MC1R DSE (16). However, it was unclear whether
other uridines, positioned at  3/ 4,  11/ 12nt down-
stream of the cleavage site are also required for its
function (Figure 1A). We thus created an additional con-
struct ‘mut1240, which has uridines at positions  3/ 4,
 11/ 12 and  31/ 32/ 33 substituted with cytidines
(Figure 1A). This plasmid was transiently transfected
into HEK293 cells and total RNA analysed by RNAse
protection (RP) using an antisense riboprobe complemen-
tary to sequences overlapping the MC1R poly(A) site.
Changing the uridines at these three positions had only
a marginal effect on the cleavage at the MC1R poly(A)
site (Figure 1B: lane mut124). In contrast, when both or a
single uridine at positions  24/ 25 are substituted,
cleavage and polyadenylation efﬁciency is signiﬁcantly
reduced (Figure 1B: lanes mut3 and mut3*) conﬁrming
that the MC1R DSE surprisingly, only requires a
di-uridine. We next analysed whether the UU needs to
be positioned at a precise distance between both the
hexamer and GB1 to be functional. To address this, we
mutated the sequences surrounding the  24/ 25 uridines
altering the distance to the cleavage site and the down-
stream GB1. Increasing the distance between the UU
and GB1 with the insertion of a 6-nt long spacer,
severely reduced cleavage efﬁciency (Figure 1C: lane
 24/ 15). Cleavage levels were not affected if the
distance between the UU and GB1 in the spacing con-
struct is reverted to 9nt by deleting the 6nt adjacent to
the UU (Figure 1C: lane  24/ 9*). Remarkably, if a
di-uridine is positioned 22nt downstream of the hexamer
and 8nt upstream of GB1, cleavage was reduced by
almost 3-fold (Figure 1C: lane  22/ 8). These results
indicate that the MC1R poly(A) site has an unusual
DSE in which a di-uridine must be at a precise distance
from both the hexamer and GB1.
As mentioned above, our earlier work also showed that
the MC1R PAS requires two GRS elements which are
separated by  400nt. We speculated that GB2 may be
brought into close proximity to the actual site of process-
ing either by folding of the RNA sequence between GB1
and GB2 or by a complex interaction of multiple proteins
that connect GB2 with the other elements. To test whether
GB2 can function when positioned adjacent to the other
cis-elements, we constructed three additional reporter con-
structs (Figure 1A, bottom graphs). In these plasmids
the region between the two G-boxes was deleted and as
a consequence GB1 is fused with either parts or the entire
sequence of GB2. RP analysis of these constructs showed
that GB2 can function when it is fused downstream of
GB1 and that the entire sequence element of GB2 is
required for optimal cleavage efﬁciency (Figure 1D).
From these results we conclude that the MC1R pre-
mRNA contains an unusual PAS with rigid positional
and structural arrangements of four individual sequence
components, the hexamer, a di-uridine, GB1 and GB2. In
addition, these data show that cleavage and polyadenyla-
tion at the MC1R 30-end processing site is inefﬁcient and
results in signiﬁcant amounts of uncleaved readthrough
transcripts (RT; Figure 1B, C and D). This was particu-
larly evident when poly(A) cleavage efﬁciency in the
MC1R plasmid was compared to a similar reporter con-
struct that contains the melanocortin 4 receptor (MC4R)
30-UTR and 30-ﬂanking sequences including the PAS (24).
In contrast to MC1R transfected cells, no readthrough
can be detected by RP of total RNA transfected with
the plasmid containing the MC4R PAS (Figure 1E).
MC1R transcripts that are not cleaved at the poly(A)
site can create chimeric MC1R TUBB3 transcripts
The above described analysis revealed the complex archi-
tecture of the 30-end processing and showed that cleavage
and polyadenylation at the MC1R poly(A) site is extre-
mely inefﬁcient. These observation indicated that either
the complex MC1R PAS is suboptimal or that additional
sequences, located downstream of GB2 (thus absent in the
minigenes), afford efﬁcient poly(A) cleavage in a genomic
context. Consequently we created a new reporter gene
(pCMTR) that contains the entire MC1R locus with
14kb of sequence 30 of the MC1R poly(A) site including
exon1, intron1 and exon2 of the downstream positioned
neuronally restricted TUBB3 gene (Figure 2A). The
TUBB3 exon2 in this construct is fused in frame to the
open reading frame (ORF) of the red ﬂuorescent protein
(RFP) located upstream of a synthetic poly(A) site (SPA)
(Figure 2A). A second construct pCMTR, identical to
pCMTR lacking the CMV promoter that drives transcrip-
tion of the MC1R gene in the former construct was built.
These plasmids not only enabled us to address whether
additional downstream sequences are required for
optimal cleavage but also to investigate how readthrough
transcription at the MC1R poly(A) site affects the TUBB3
transcription locus. The latter is important since inefﬁcient
30-end processing and subsequent failure to terminate the
2380 Nucleic Acids Research, 2011,Vol.39, No. 6transcribing RNA polymerase II (polII) can affect the
expression of closely positioned downstream genes by
transcriptional interference (25).
RP analysis of RNA isolated from transfected HEK293
cells shows that signiﬁcantly less uncleaved pre-mRNA is
detected with the pCMTR construct than was previously
observed with the minigenes (Figure 2B). This suggests
that either additional sequences positioned downstream
of GB2 may be essential in directing efﬁcient cleavage
and polyadenylation at the MC1R poly(A) site or that
the readthrough transcripts from the pCMTR construct
are more efﬁciently turned over compared to the uncleaved
RNAs from the minigenes. However, as readthrough tran-
scripts could still be detected in pCMTR transfected
cells, we proceeded to analyse whether this affects the
downstream positioned TUBB3 gene. We therefore
compared RFP expression in cells transfected either with
pCMTR or pCMTR. Surprisingly, cells transfected with
the pCMTR constructs clearly expressed RFP but no
ﬂuorescence could be detected in cells transfected with the
100  37   88  23             100   26  36  83
±7  ±11 ±14                        ±6  ±11 ±24
B
RT
A
pA
MC1R
5’UTR
MC1R 3’UTR 760bp
CMV GFP
MC1R 3’flank 1kb pUC-18
RT175 
pA 110
AATAAATGTGACTCAGCATCACCCACCTTAGCCCCTTCCAGAAAGTGCTTGAAGTTTGCGGGTGGAGGGATGGGGGAGGGGAAGG
-3/-4 -11/-12 -24/-25 -31/-32/-33 GB1
mut3                                                 CCTTAGCCCCTTCCAGAAAGTGCCCGAAGTTTGC
mut124                                             CCCCAGCCCCCCCCAGAAAGTGCTTGAAGCCCGC
mut3*                                                CCTTAGCCCCTTCCAGAAAGTGCTCGAAGTTTGC
DSE
W
t
m
u
t
3
m
u
t
1
2
4
m
u
t
3
*
pA
CCCACCTTAGCCCCTTCCAGAAAGTGCTTGAAGTTTGCGGGTGGAGGGATG
9 23
CCCACCTTAGCCCCTTCCAGAAAGTGCTTGAAGTTTagcagcGCGGGTGGAGGGATG -24/-15
-22/-8
-24/-9*
CCCACCTTAGCCCCTTCCAGAAAGTTTagcagcGCGGGTGGAGGGATG
CCCACCTTAGCCCCTTCCAGAAAGTGCTTTagcagcGCGGGTGGAGGGATG
Wt (-24/-9)
-
2
4
/
-
1
5
-
2
2
/
-
8
-
2
4
/
-
9
*
W
t
 
RT
pA
100   8   40  52 53  94
±1   ±7   ±3 ±8  ±26
W
t
h
3
6
G
1
G
1
G
2
b
G
1
G
2
a
G
1
G
2
a
b
GFP
G1 G2
b
GFP
GFP
GFP
GFP
Wt
h36
G1
G1G2b
G1G2a
G1G2ab
GFP
a
CD E
RT
pA
pA
RT
M
C
1
R
 
(
W
t
)
M
C
4
R
12 3 4
Rel. pA
Figure 1. The MC1R poly(A) site has a complex sequence arrangement and is inefﬁcient. (A) Outline of the MC1R parental minigene plasmid. The
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diagonal line). The position and length of the RP probe spanning the poly(A) site and the protected fragment lengths (RT, pA) are shown. (B–D)R P
analysis of total RNA isolated from HEK293 cells transiently transfected with wild-type and mutant plasmids. Cleaved (pA) and non-cleaved
readthrough (RT) protected fragments are indicated on the side of the gels. Quantitation of three independent transfections for each plasmid
displayed as pA/RT ratio (rel. pA) with standard deviation indicated below each lane; the wt ratio is set to 100%. (E) RP comparing the levels
of poly(A) readthrough (RT) and 30-end processed transcripts (pA) between plasmids containing the MC4R 30-UTR and poly(A) sequences (MC4R)
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indicates that the neuronally restricted TUBB3 promoter
is inactive on the pCMTR plasmid when transfected into
HEK293 cells. To verify whether potential readthrough at
the MC1R poly(A) site somehow renders the neuronally
restricted TUBB3 promoter active in the pCMTR
context, we used an RP probe spanning the annotated
TUBB3 promoter and ﬂanking sequences (Figure 2A:
TP). RP analysis of total RNA isolated from cells trans-
fected with pCMTR indicated that the TUBB3 promoter is
inactive (Figure 2D, lane 3). In contrast, a protected band
representing transcription from the TUBB3 promoter is
clearly visible when a construct (pCMTRi) lacking the
9.1-kb long ﬁrst intron is transfected (Figure 2D, lane 4).
This not only validated our ﬁnding that the TUBB3
promoter in the pCMTR is inactive but also showed that
the TUBB3 intron1 is likely to play a role in the inactiva-
tion of its promoter on the plasmid and we are currently
further investigating this phenomenon. RP analysis using a
probe against the MC1R poly(A) site conﬁrms that the
RNA isolated from the pCMTR transfected cells is intact
and that the failure to detect a band corresponding to tran-
scription from the TUBB3 promoter is not due to degrad-
ation of the RNA in this sample or transfection efﬁciency
(Figure 2D: lanes 1 and 2).
As no transcription from the TUBB3 promoter could be
detected by RP in pCMTR, we speculated that the expres-
sion of RFP could be the result of a complex splicing
reaction creating a transcript that originates from the
CMV promoter and contains the TUBB3/RFP ORF.
This is plausible since the inefﬁcient MC1R PAS may
result in the formation of a large fusion primary transcript
containing the entire MC1R and TUBB3/RFP gene.
Splicing of this pre-mRNA could then result in an
mRNA capable of expressing RFP. To test this possibility
we used an RP approach to identify potential 50-splice site
(50-SS) located in the MC1R gene. We ﬁrst used an RP
probe spanning the entire 50-UTR and analysed RNA
isolated from pCMTR transfected cells but failed to
detected any protected bands indicative of the presence
of a 50-SS (data not shown). In contrast, when we
employed an RP probe complementary to sequences
overlapping the MC1R ORF and 30-UTR (Figure 2A:
SP), we detected, in addition to the expected unspliced
MC1R mRNA (uS), a shorter band (S) which could rep-
resent a spliced mRNA (Figure 2E). Interestingly, a minor
spliced isoform of MC1R has been isolated from human
testis (26). This isoform is created by a splicing event that
uses a 50-SS located at the end of the MC1R ORF and a
30-splice site (30-SS) in the MC1R 30-UTR and then ter-
minates at the MC1R PAS. This mRNA encodes an
MC1R receptor with a short additional C-terminal
extension.
The RP results allowed us to design speciﬁc RT–PCR
primers to test whether RFP expression in pCMTR trans-
fected cells is indeed the result of a splicing event. We
therefore PCR ampliﬁed oligo dT primed cDNA of
RNA isolated from pCMTR transfected HEK293 cells
with a forward primer located in the MC1R ORF and a
reverse primer complementary to sequences in the RFP
ORF (Figure 2A: F1, RR). This PCR reactions resulted
in two speciﬁc products, isoform 1 and 2 (Figure 2F).
Subsequent re-ampliﬁcation and sequencing of the two
products conﬁrmed two alternatively spliced chimeric
MC1R-RFP mRNAs using the above described 50-SS.
Interestingly, isoform 1 is the result of two splicing
events fusing the MC1R ORF to an exon, 1a, located in
the MC1R 30-UTR which is then joined in frame with
exon2/RFP ORF (Figure 2G). Notably, the 30-SS of
exon 1a is identical to the above described isoform
reported by (26). This transcript encodes an in frame
MC1R-RFP protein explaining why pCMTR transfected
cells are ﬂuorescent. The second isoform is the result of a
single splicing event fusing the 50-SS to exon2/RFP
creating a chimeric transcript where the RFP ORF is
out of frame.
The above described analysis suggested that the MC1R
poly(A) site may have evolved to be inefﬁcient to allow a
signiﬁcant number of polymerases to read through the
30-end processing site enabling the formation of alterna-
tively spliced MC1R-TUBB3 chimeric transcripts. Thus,
the reduction in readthrough RNAs in pCMTR trans-
fected cells may not be due to the presence of additional
auxiliary sequence elements that enhance the MC1R
poly(A) site but instead, levels of readthrough RNAs are
reduced because these transcripts are further processed
and subjected to splicing.
Modulating poly(A) site strength affects chimeric
formation
The inefﬁcient MC1R PAS may be a critical feature
allowing alternative processing of transcripts in the
MC1R TUBB3 locus. If this were true, artiﬁcial inactiva-
tion or strengthening of the MC1R poly(A) site should
have opposing effects on the levels of chimeric transcripts
that are produced. We therefore created four add-
itional plasmids from the parental pCMTR construct
(Figure 3A). First we deleted a fragment including the
intergenic region (iG) and TUBB3 promoter, exon1 and
most of intron1 resulting in the plasmid pCiG. This
clone effectively brings the 30-SS of the TUBB3 exon2
and the MC1R 50-SS into close proximity. This novel
sequence arrangement may favour splicing over cleavage
and polyadenylation at the MC1R poly(A) site and tip the
balance from MC1R transcripts towards MC1R-TUBB3
chimeric mRNAs. To simplify cloning of the replacement
of the MC1R PAS with the strong synthetic SPA process-
ing signal (23) a construct (pC6ki1) was prepared where
a 6.2-kb deletion of sequences in intron1 brings the
TUBB3 30-SS closer to the 50-SS in the MC1R ORF.
The MC1R AATAAA and the DSE in this plasmid was
then replaced by SPA giving rise to the pCSPA6ki1 con-
struct. Finally, a fourth plasmid was built in which 1.2kb
of 30-ﬂanking sequences including GB1 to GB2 were
replaced by 1.2kb of sequence from pUC18. The MC1R
30-end processing signal in this construct is similar to the
earlier described H36 clone which dramatically reduces the
cleavage efﬁciency of the MC1R PAS (16). The four
plasmids were transiently transfected into HEK293 cells
and quantitative effects on MC1R and MC1R-TUBB3
chimeric expression was assessed by RP using antisense
Nucleic Acids Research,2011, Vol.39, No. 6 2383probes complementary to sequences of the MC1R 50-UTR
(measuring total output), MC1R 50-SS (measuring spliced
versus unspliced mRNAs), TUBB3 promoter (measuring
promoter activation) and RFP (measuring chimera pro-
duction) (Figure 3A). The total transcriptional output
from all four constructs was measured (Figure 3B: 50
panel). Splicing at the MC1R 50-SS dramatically increased
in plasmids where the distance between the 50-SS and the
30-SS was reduced (Figure 3B: pCiG, pC6ki1, panel
SP). A similar increase in 50-SS usage is also observed
when the MC1R poly(A) site is inactivated by the replace-
ment of the GB1 and GB2 by ‘neutral’ pUC18 sequences
(Figure 3B: pCG1G2). In these constructs, the levels of
RFP message was also signiﬁcantly higher compared to
transcripts analysed from pCMTR transfected cells
(Figure 3B and C: 2R panel). The increase in RFP
message in the pCiG and pC6ki1 was not due to acti-
vation of the TUBB3 promoter which is evidenced by the
lack of any protected bands when the TUBB3 promoter
speciﬁc RP probe was employed (Figure 3B and C:TP
panel). In contrast, when the inefﬁcient MC1R poly(A)
site was replaced by the strong synthetic SPA 30-end pro-
cessing signal, both splicing at the MC1R 50-SS and the
levels of RFP message were dramatically reduced
compared to pCMTR and importantly its parental
pC6ki construct. This result suggests that the presence
of an inefﬁcient poly(A) site in the MC1R gene is essential
in allowing the production of MC1R-TUBB3 chimeric
transcripts. These results further imply that modulating
the strength of the MC1R poly(A) site or the splice sites
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2384 Nucleic Acids Research, 2011,Vol.39, No. 6by potential trans-factors may be a process by which ex-
pression ratios between MC1R and the chimeric tran-
scripts could be regulated.
MC1R-TUBB3 chimeric transcripts are far more
abundant in human than in mouse melanocytes
To establish the signiﬁcance of the results described above,
we investigated whether similar endogenous transcripts, as
obtained by transfecting pCMTR into MC1R negative
HEK293 cells, are expressed in mammalian melanocytes.
We therefore isolated total RNA from two well-
established human melanoma derived cell lines: M14 and
HBL and performed an RP analysis with the above
described antisense probe complementary to the region
encompassing the MC1R 50-SS. In this experiment, en-
dogenous spliced and unspliced MC1R transcripts could
be detected by RP in both melanoma derived M14 and
HBL RNA but were absent in untransfected HEK293
control RNA (Figure 4B). This conﬁrms that the 50-SS
identiﬁed in the MC1R ORF, is also used in a signiﬁcant
amount of endogenous MC1R transcripts. To verify if
splicing of endogenous MC1R transcripts produces
MC1R-TUBB3 chimera as detected in HEK293 cells
transfected with pCMTR, we subjected total RNA
isolated from both cell lines to RT–PCR analysis. RNA
was reverse transcribed using oligo dT and cDNAs were
subsequently ampliﬁed by PCR employing gene speciﬁc
primers capable of amplifying MC1R and potential
fusion transcripts as indicated in Figure 4A. In both
melanoma derived cell lines M14 and HBL cells as well
as in the immortalized melanocyte cell line HERMES-1
(22), MC1R and two chimeric transcript isoforms can be
detected by RT–PCR (Figure 4C, D and E). The bands
representing the two isoforms were gel isolated,
re-ampliﬁed and sequenced. Sequencing conﬁrmed that
isoform 1 contains the ORF of the MC1R coding region
fused to exon 1a located in the MC1R 30-UTR which is
joined to exon 2, 3 and 4 of the TUBB3 gene. This mRNA
contains an uninterrupted ORF encoding a 797 amino
acid long seven transmembrane MC1R receptor protein
with a C-terminal TUBB3 extension (Supplementary
Figure S1). The second isoform is a chimeric transcript
that is identical to isoform 1 but skips the exon 1a in the
MC1R 30-UTR (Supplementary Figure S2). The conse-
quence of this exon skipping is an mRNA with a shorter
432 amino acid long ORF that encodes for an MC1R
receptor protein with a C-terminal extension that is out
of frame with the human TUBB3 ORF. However, the
115 amino acid C-terminal extension of the MC1R
receptor in isoform 2, in a ‘Blast’ search, showed some
similarities with the chicken TUBB3 protein. From these
results we concluded that human melanocytes express at
least three MC1R isoform mRNAs, encoding the MC1R
receptor and two additional receptors that contain
C-terminal extensions of TUBB3.
To verify whether chimeric transcripts were also ex-
pressed in melanocytes from furred animals we analysed
total RNA isolated from B16, pigmented Melan-a melano-
cytes and the albino Melan-c melanocyte cell line. The
MC1R and TUBB3 coding sequences between mouse
and human are highly conserved and as a consequence, a
50-SS with sequences identical to the human equivalent is
also present in the mouse MC1R ORF. Surprisingly
though, despite being able to easily amplify MC1R
from all mouse derived cell lines (Figure 4G: F1mdT:
B16, Melan-a, Melan-c) we were unable to detect any tran-
scripts representing MC1R-TUBB3 fusion proteins.
Notably, we unsuccessfully used multiple sets of reverse
PCR primers complementary to sequences in the
mouse TUBB3 exon 4. This included two PCR primers
(Figure 4F: R4U and F1U) that are complementary to
regions in MC1R and TUBB3 that are identical in
sequence between mouse and humans. Although this
primer pair was able to amplify human chimeric tran-
scripts no such mRNAs were detected with RNA isolated
from mouse melanocytes (data not shown). Furthermore,
at best, only trace amounts of a band potentially repre-
senting chimeric transcripts could be detected from
mouse total RNA compared to human even when we
used a gene speciﬁc reverse primer R4U (Supplementary
Figure S3). We therefore conclude that unlike human mel-
anocytes, mouse derived melanocytes do not express sig-
niﬁcant amounts of detectable MC1R-TUBB3 chimeric
mRNAs possibly due to the different poly(A) arrangement
in the mouse MC1R gene (Supplementary Figure S4).
Mouse melanocytes can create MC1R-TUBB3 chimeric
transcripts when a plasmid containing the human sequence
is transfected
As shown above, mouse melanocytes appear to be unable
to produce MC1R-TUBB3 signiﬁcant amounts of
chimeric transcripts. This was surprising given that the
mouse TUBB3 intron 1 is signiﬁcantly shorter than its
human counterpart positioning the 50-SS in the mouse
ORF closer to the TUBB3 exon 2 30-SS. According to
the results presented above, this should favour splicing
between MC1R and TUBB3 exons (Figure 3B). Two
reasons could account for this observation: (i) mouse mel-
anocytes either lack a potential trans-factor, or (ii) the
sequences present in the mouse MC1R-TUBB3 locus do
not support the alternative splicing event. To clarify this,
we transfected the pCMTR plasmid into B16 mouse mel-
anocytes and isolated RNA was subsequently analysed
by RP using multiple RP probes (Figure 5A). Mouse
melanocytes recognize the human MC1R poly(A) site
less efﬁciently and show a higher degree of spliced
versus unspliced transcripts relative to HEK293 cells.
The increased level of splicing from the MC1R 50-SS is
mirrored by a similar increase in TUBB3 exon2-RFP
containing RNA indicative of efﬁcient intersplicing
between MC1R and TUBB3 (Figure 5B). Importantly,
this increase is not due to transcription from the TUBB3
promoter as is evidenced by RP (Figure 5B: TP panel) and
the formation of chimeric transcripts was subsequently
conﬁrmed by RT–PCR (Figure 5C). Thus these results
indicate that the mouse melanocytes are able to produce
chimeric transcripts in the correct sequence environment.
The lack of endogenous MC1R-TUBB3 chimeric tran-
scripts in mouse melanocytes is therefore likely to be due
Nucleic Acids Research,2011, Vol.39, No. 6 2385to sequence constraints in the mouse rather than due to
the lack of a speciﬁc trans-factor(s).
The relative levels of MC1R and MC1R-TUBB3 chimeric
transcripts can be modulated by a-MSH and MKK6
Our results presented above clearly show that human mel-
anocytes express endogenous MC1R-TUBB3 chimeric
transcripts, but it was unclear whether the expression of
these alternatively processed isoforms can be related to
facultative pigmentation in humans. When skin is
exposed to solar radiation, the major signalling molecule
a-MSH is secreted by keratinocytes. a-MSH binds MC1R
and elevates intracellular cAMP levels in melanocytes
activating expression of the microphthalmia-associated
transcription factor (MITF) that controls the expression of
multiple genes involved in melanogenesis (9). As a-MSH
has been proposed to affect MC1R expression (12), we
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2386 Nucleic Acids Research, 2011,Vol.39, No. 6next tested whether exposure of human melanocytes to
a-MSH has any impact on the expression patterns of
MC1R and MC1R-TUBB3 chimeric transcripts. In this
analysis we exposed human HBL melanoma derived mel-
anocytes for 0, 1, 3 or 5 days to 10nM a-MSH and subse-
quently monitored the expression pattern of both MC1R
and the chimeric transcripts by RT–PCR. Exposure of
the melanocytes to a-MSH for 3–5 days notably changed
the levels of both MC1R and chimeric transcripts.
Whereas the levels of MC1R transcripts dropped after
exposure to a-MSH, the chimeric transcript levels dramat-
ically increasedover the same period(Figure 6A). Asimilar
result was obtained when the melanocyte derived
HERMES cell line was exposed to prolonged a-MSH
treatment (Supplementary Figure S5). Interestingly, when
a PCR was performed using the same HBL derived cDNA
andaforwardprimer inthe 50-UTRandareverse primer in
MC1R ORF (detecting the total output MC1R and
MC1R-TUBB3 transcripts) no signiﬁcant change in tran-
script levels was observed between the different time points
(Figure 6A: MC1R 50-ORF). This implies that the overall
output is not affected. Taken together, these results
indicate that exposure of human melanocytes to a-MSH
shifts the expression from predominantly MC1R, in the
resting stage, to MC1R-TUBB3 chimera in the activated
stage.
Exposure of melanocytes to a-MSH not only regulates
MITF expression but also activates the RAS-BRAF-ERK
(27)-signalling cascade and stimulates the p38 MAPK-
signalling pathway (28). In order to dissect which of the
pathways stimulated by a-MSH may account for the
observed ratio change of MC1R and MC1R-TUBB3
chimeras, we over expressed MITF (Figure 6B), constitu-
tively active BRAF
V600E (Figure 6C) and the constitutively
active MKK6 mutant MKK6E (Figure 6C). Although all
the mRNAs of the three factors could be over expressed in
HBL melanocytes (Figure 6B and C: expression controls)
only over expression of MKK6E had a signiﬁcant impact
on MC1R isoform expression. Over expression of MKK6E
resulted in a dramatic increase in the chimeric isoforms but
left MC1R levels unaffected (Figure 6C: Iso1/Iso2, lane:
pE_MKK6E).
Since transfection of MKK6E dramatically increased
MC1R-TUBB3 chimera formation in human melanocytes,
we next tested whether we could force mouse melanocytes
to create chimeric transcripts by over expressing MKK6E.
AscanbeseeninFigure6D,overexpressionofBRAF
V600E
or MKK6E failed to trigger chimera production in mouse
melanocytes, further conﬁrming that the mouse MC1R-
TUBB3 locus somehow does not allow inter-splicing.
We thus conclude that the expression of chimeric
MC1R-TUBB3 transcripts in human melanocytes is
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2388 Nucleic Acids Research, 2011,Vol.39, No. 6regulated in response to a-MSH and MC1R chimera
formation is increased upon the activation of the
p38-signalling pathway.
The two chimeric transcripts produce viable proteins
and over expressed isoform 1 can be detected in the
cell membrane
We have demonstrated that alternatively spliced mRNA
isoforms containing MC1R and TUBB3 sequences are
present in human melanocytes. However, we needed to
clarify whether these transcripts produce detectable
chimeric proteins and if so, to identify their subcellular
localization. To that end, we cloned three expression
plasmids encoding MC1R, the MC1R-TUBB3 fusion
protein isoforms 1 (Iso1) and 2 (Iso2) (Figure 7A).
Western blot analysis conﬁrmed that MC1R and both
chimeric proteins are produced in transiently transfected
HEK293 cells (Figure 7B). Interestingly, the chimeric
protein isoform 1 was consistently detected at much
higher levels than either MC1R or isoform 2.
Importantly, by using a MC1R speciﬁc antibody and
confocal microscopy, we show that both MC1R and
MC1R-TUBB3 isoform 1 are localized in the cell
membrane of transfected HEK293 cells (Figure 7C). This
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Nucleic Acids Research,2011, Vol.39, No. 6 2389is in stark contrast to the chimeric protein isoform 2,
which appears to be retained in the ER or nuclear
membrane.
We next tested whether the TUBB3 C-terminal exten-
sion changes the receptor subunit’s ability to respond to
a-MSH and elevate intracellular cAMP levels. We there-
fore expressed MC1R, MC1R-TUBB3 isoform 1 and 2 in
HEK293 cells and assayed cAMP levels after exposure of
the transfected cells to a-MSH. Whilst MC1R-TUBB3
chimeric isoform 1 has a notably reduced activity,
isoform 2 failed to elevate cAMP levels in HEK293 cells
exposed to a-MSH (Figure 7D).
From these experiments we conclude that in our system
the chimeric MC1R-TUBB3 protein isoforms have a sig-
niﬁcantly reduced capacity to elevate intracellular cAMP
levels in response to a-MSH and may thus contribute to
the desensitization of the melanocytes for a-MSH.
DISCUSSION
By subjecting pre-mRNAs to alternative splicing and al-
ternative 30-end processing eukaryotic cells are able to
generate a variety of mRNA isoforms and also expand
their proteome which dramatically increases their
capacity to respond to cellular and environmental cues.
In recent years alternative splicing and alternative
polyadenylation (29) have been studied extensively.
Alternative 30-end pre-mRNA processing to date has
focussed almost entirely on the generation of alternative
transcripts from one particular gene. The ﬁeld paid little
or no attention to reports which suggest that alternative
cleavage and polyadenylation coupled with alternative
splicing is not limited to one gene but may frequently
occur between genes positioned in tandem (30,31).
Although such intergenic alternative poly(A) events are
relatively well documented by bioinformatic studies only
a handful of examples have been characterized at the mo-
lecular level (32–36).
The results presented in this paper provide dramatic
evidence that alternative splicing combined with alterna-
tive polyadenylation can increase the available proteome
even further by combining exons from different genes.
Thus, ‘inter-splicing’ between closely in-tandem arranged
genes may play a much more important role in eukaryotic
gene expression than was previously thought.
Alternative pre-mRNA processing within the MC1R
locus demonstrates that an inefﬁcient and/or kinetically
slow 30-end processing site (Figures 1–3) is a prerequisite
for inter-splicing between genes. Therefore, the regulation
of suboptimal PAS between closely spaced genes may play
a critical role in the regulation of poly(A) cleavage, sub-
sequent transcription termination of pol II and ultimately
control chimera formation.
Interestingly, we show that expression levels of the
MC1R and the MC1R-TUBB3 chimeric transcripts can
be modulated by artiﬁcially activating signalling
pathways that are stimulated in melanocytes when skin
is exposed to solar radiation. Prolonged exposure to
a-MSH reduces MC1R mRNA levels but increases
chimeric transcript levels (Figure 6). a-MSH exposure
results in elevation of cAMP levels in melanocytes trigger-
ing a multifaceted response that includes the known acti-
vation of the transcription factor MITF, stimulation of
the RAS/BRAF/ERK kinase pathway and induces the
p38 stress response pathway. The sum of this signalling
cascade is the activation of a large number of genes that
are required for melanogenesis. Surprisingly, over expres-
sion of MITF and the constitutively active BRAF
V600E
kinase had little effect on either the MC1R or chimeric
transcript levels. In contrast, expression of MKK6E, a
kinase speciﬁcally associated with the p38 pathway, sig-
niﬁcantly changes the levels of chimeric transcripts but
had no impact on MC1R mRNA levels. This suggests
that the increase in chimeric mRNAs observed when
cells were exposed to a-MSH can at least in part be ex-
plained by the activation of the p38 pathway. Modulation
of chimeric transcript levels may be achieved at multiple
steps including mRNA stability, regulation of MC1R
poly(A) site efﬁciency and activation of alternative
splicing. Intriguingly, activation of the p38 pathway has
previously been shown to affect transcript stability, albeit
mostly of mRNAs harbouring speciﬁc destabilizing A/U
rich elements in their 30-UTRs that are not obvious in the
chimeric transcript (37,38). However, the reduction in
MC1R transcripts observed when melanocytes are
exposed to a-MSH must be the consequence of the acti-
vation of an additional unknown factor or pathway that
triggers destabilization of the MC1R mRNA or increases
intersplicing possibly by modulation the strength of the
MC1R poly(A) site.
As mentioned above, expression levels of both MC1R
and the chimeric transcripts are modulated by kinase
pathways that are normally activated in human skin in
response to the exposure to solar radiation. This ﬁnding
makes it very likely that the chimeric receptors play an
important role in the facultative pigmentation system in
humans. The fact that both MC1R-TUBB3 chimeric re-
ceptors have a signiﬁcantly reduced capacity to elevate
intracellular cAMP levels upon exposure to a-MSH are
important observations for their possible function
(Figure 7). The reduction of MC1R transcripts and the
concomitant increase of the chimeric mRNAs after a pro-
longed exposure to high levels of a-MSH may effectively
desensitizes the melanocytes to a-MSH by forcing a switch
in receptor isoform expression. MC1R is rapidly
desensitized in the classical way by G protein-coupled
receptor kinases and possibly subsequent internalization
(39). However, a switch in receptor isoform expression
would ensure that the MC1R receptor pool would not
be replenished during the prolonged exposure of activated
melanocytes to a-MSH and desensitize melanocytes once
they are fully activated. This may prevent overstimulation
of melanocytes during prolonged exposure of the skin to
solar radiation. The importance of a complex a-MSH de-
sensitization mechanism in human melanocytes may be a
prerequisite of UVR induced skin pigmentation and thus
explain why chimeric protein receptors are absent in
mouse melanocytes.
However, the function of the chimeric MC1R-TUBB3
proteins may not be limited to a role in the desensitization
process. In particular, given that MC1R has been shown
2390 Nucleic Acids Research, 2011,Vol.39, No. 6to dimerize (40), heterodimerization between MC1R and
either of the chimera or the chimeras themselves may
result in alternative signalling capacities and events.
Finally the chimeric proteins themselves represent an
intriguing link between a signalling receptor and a com-
ponent of the cytoskeleton. This may be of particular
importance as morphological changes, including the for-
mation of dendrites during melanogenesis, is an essential
process to afford UVR protection of human skin by
tanning. Interestingly, TUBB3 is known to affect a/b
tubulin dynamics and has been implicated in neuronal
dendrite formation (41). We therefore propose that the
MC1R-TUBB3 chimeric receptor may play a role in the
rearrangement of the cytoskeleton that is required to
initiate, propagate and guide the dendrites of activated
melanocytes along an a-MSH gradient towards the kera-
tinocytes. A critical role of the chimera during dendrite
formation may also explain why the MC1R TUBB3 locus
in mouse is unable to direct intersplicing between MC1R
and TUBB3 (Figure 4) as tanning is not a necessary adap-
tation in furred skin.
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